A

Apimeds Pharmaceuticals US Inc.
D

APUS

2.18000
USD
0.22
(11.22%)
مغلق
حجم التداول
1,447
الربح لكل سهم
0
العائد الربحي
-
P/E
-6
حجم السوق
27,415,643
المقالات

العنوان: Apimeds Pharmaceuticals US Inc.

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Apimeds Pharmaceuticals Us Inc is a clinical-stage company. It is engaged in a pharmaceutical business that provides the biological drug Apitox to clients in the biological drug commercial transaction area. It are a clinical stage biopharmaceutical company in the process of developing Apitox, an intradermally administered bee venom-based toxin. Company focus is on developing therapies that address inflammation and pain management symptoms associated with knee OA and, to a lesser extent, MS. Apitox is currently marketed and sold by Apimeds Inc. in South Korea as Apitoxin for the treatment of OA.